| Year |
Citation |
Score |
| 2020 |
van Westrhenen R, Aitchison KJ, Ingelman-Sundberg M, Jukić MM. Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going? Frontiers in Psychiatry. 11: 94. PMID 32226396 DOI: 10.3389/Fpsyt.2020.00094 |
0.341 |
|
| 2019 |
Lodhi RJ, Wang Y, Macintyre G, Crocker C, Loverock A, Henriques BC, Heywood B, Sivapalan S, Bowker A, Majeau B, Bolt C, Bugbee D, Newton V, Tibbo P, Purdon SE, ... Aitchison KJ, et al. Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis. Psychiatry Research. 280: 112500. PMID 31445421 DOI: 10.1016/J.Psychres.2019.112500 |
0.324 |
|
| 2019 |
Madsen T, Buttenschøn HN, Uher R, Behrendt-Møller I, Perroud N, Maier W, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Rietschel M, McGuffin P, Aitchison KJ, Mors O, Köhler-Forsberg O. Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 80. PMID 31318184 DOI: 10.4088/Jcp.18M12575 |
0.315 |
|
| 2019 |
Leirer DJ, Iyegbe CO, Di Forti M, Patel H, Carra E, Fraietta S, Colizzi M, Mondelli V, Quattrone D, Lally J, Ajnakina O, Lee SH, Curtis CJ, Breen G, Pariante C, ... Aitchison K, et al. Differential gene expression analysis in blood of first episode psychosis patients. Schizophrenia Research. PMID 31113746 DOI: 10.1016/J.Schres.2019.05.011 |
0.314 |
|
| 2019 |
Bin Wei Y, McCarthy M, Ren H, Carrillo-Roa T, Shekhtman T, DeModena A, Liu JJ, Leckband SG, Mors O, Rietschel M, Henigsberg N, Cattaneo A, Binder EB, Aitchison KJ, Kelsoe JR. A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression. Molecular Psychiatry. PMID 30874608 DOI: 10.1038/S41380-019-0397-1 |
0.429 |
|
| 2019 |
Köhler-Forsberg O, Larsen ER, Buttenschøn HN, Rietschel M, Hauser J, Souery D, Maier W, Farmer A, McGuffin P, Aitchison KJ, Uher R, Mors O. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 30698114 DOI: 10.1192/Bjp.2018.302 |
0.331 |
|
| 2019 |
Zwicker A, Fabbri C, Gaston D, Denovan-Wright EM, Aitchison K, Peter M, Lewis CM, Perlis R, Castro V, Uher R. GENETIC DETERMINANTS OF WEIGHT CHANGE DURING ANTIDEPRESSANT TREATMENT WITH SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS: GENOME-WIDE STUDY AND META-ANALYSIS European Neuropsychopharmacology. 29: S1000. DOI: 10.1016/J.Euroneuro.2017.08.390 |
0.363 |
|
| 2019 |
Ren H, Fabbri C, Uher R, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Farmer A, McGuffin P, Lewis C, Aitchison K. Genome-Wide Association Study Of Anhedonia In Gendep Using A Linear Mixed Model Identifies Candidates With Relevant Biological Function European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.345 |
0.378 |
|
| 2018 |
Fabbri C, Tansey KE, Perlis RH, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Lee SH, Newhouse S, Patel H, ... ... Aitchison KJ, et al. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 945-954. PMID 30135031 DOI: 10.1016/J.Euroneuro.2018.05.009 |
0.354 |
|
| 2018 |
Zwicker A, Fabbri C, Rietschel M, Hauser J, Mors O, Maier W, Zobel A, Farmer A, Aitchison KJ, McGuffin P, Lewis CM, Uher R. Genetic disposition to inflammation and response to antidepressants in major depressive disorder. Journal of Psychiatric Research. 105: 17-22. PMID 30130674 DOI: 10.1016/J.Jpsychires.2018.08.011 |
0.345 |
|
| 2018 |
Ren H, Fabbri C, Uher R, Rietschel M, Mors O, Henigsberg N, Hauser J, Zobel A, Maier W, Dernovsek MZ, Souery D, Cattaneo A, Breen G, Craig IW, Farmer AE, ... ... Aitchison KJ, et al. Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP). Translational Psychiatry. 8: 150. PMID 30104601 DOI: 10.1038/S41398-018-0198-3 |
0.404 |
|
| 2018 |
Iniesta R, Hodgson K, Stahl D, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Dobson R, Aitchison KJ, Farmer A, McGuffin P, et al. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables. Scientific Reports. 8: 5530. PMID 29615645 DOI: 10.1038/S41598-018-23584-Z |
0.323 |
|
| 2017 |
Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, ... Aitchison KJ, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain and Behavior. 7: e00850. PMID 29201551 DOI: 10.1002/Brb3.850 |
0.331 |
|
| 2017 |
Fabbri C, Tansey KE, Perlis RH, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Sang-Hyuk L, Newhouse S, Patel H, ... ... Aitchison KJ, et al. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation. The Pharmacogenomics Journal. PMID 29160301 DOI: 10.1038/Tpj.2017.44 |
0.412 |
|
| 2017 |
Ren H, Guan L, Zhao L, Lin Y, Wang Y, Yang Z, Li X, Ma X, Cheng X, Deng W, Aitchison KJ, Cao L, Li T. Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29135068 DOI: 10.1002/Ajmg.B.32601 |
0.366 |
|
| 2017 |
Rivera M, Locke AE, Corre T, Czamara D, Wolf C, Ching-Lopez A, Milaneschi Y, Kloiber S, Cohen-Woods S, Rucker J, Aitchison KJ, Bergmann S, Boomsma DI, Craddock N, Gill M, et al. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. The British Journal of Psychiatry : the Journal of Mental Science. PMID 28642257 DOI: 10.1192/Bjp.Bp.116.183475 |
0.356 |
|
| 2017 |
Köhler-Forsberg O, Buttenschøn HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A, Rietschel M, McGuffin P, Aitchison KJ, Uher R, Mors O. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain, Behavior, and Immunity. PMID 28257825 DOI: 10.1016/J.Bbi.2017.02.020 |
0.322 |
|
| 2017 |
García-González J, Tansey KE, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Žagar T, Czerski PM, Jerman B, Buttenschøn HN, Schulze TG, Zobel A, ... ... Aitchison KJ, et al. Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28159590 DOI: 10.1016/J.Pnpbp.2017.01.011 |
0.349 |
|
| 2016 |
Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, Euesden J, O'Reilly P, Curtis C, Kolliakou A, Patel H, Newhouse S, Traylor M, Ajnakina O, Mondelli V, Marques TR, ... ... Aitchison KJ, et al. An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis. Biological Psychiatry. PMID 27765268 DOI: 10.1016/J.Biopsych.2016.06.028 |
0.312 |
|
| 2016 |
Trotta A, Iyegbe C, Di Forti M, Sham PC, Campbell DD, Cherny SS, Mondelli V, Aitchison KJ, Murray RM, Vassos E, Fisher HL. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study. Plos One. 11: e0163319. PMID 27648571 DOI: 10.1371/Journal.Pone.0163319 |
0.347 |
|
| 2016 |
Iniesta R, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Stahl D, Dobson R, Aitchison KJ, Farmer A, Lewis CM, McGuffin P, et al. Combining clinical variables to optimize prediction of antidepressant treatment outcomes. Journal of Psychiatric Research. 78: 94-102. PMID 27089522 DOI: 10.1016/J.Jpsychires.2016.03.016 |
0.303 |
|
| 2015 |
Hodgson K, Tansey KE, Powell TR, Coppola G, Uher R, Zvezdana Dernovšek M, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison KJ, Craig IW, et al. Transcriptomics and the mechanisms of antidepressant efficacy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621261 DOI: 10.1016/J.Euroneuro.2015.10.009 |
0.349 |
|
| 2015 |
Rucker JJ, Tansey KE, Rivera M, Pinto D, Cohen-Woods S, Uher R, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, Barnes MR, Preisig M, Mors O, et al. Phenotypic Association Analyses with Copy Number Variation in Recurrent Depressive Disorder. Biological Psychiatry. PMID 25861698 DOI: 10.1016/J.Biopsych.2015.02.025 |
0.337 |
|
| 2015 |
Colizzi M, Iyegbe C, Powell J, Ursini G, Porcelli A, Bonvino A, Taurisano P, Romano R, Masellis R, Blasi G, Morgan C, Aitchison K, Mondelli V, Luzi S, Kolliakou A, et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophrenia Bulletin. PMID 25829376 DOI: 10.1093/Schbul/Sbv032 |
0.347 |
|
| 2015 |
Hodgson K, Tansey KE, Uher R, Dernovšek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Craig IW, Aitchison KJ, Farmer AE, Dobson RJ, et al. Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology. 232: 2609-17. PMID 25761838 DOI: 10.1007/S00213-015-3898-X |
0.363 |
|
| 2015 |
Legge RM, Sendi S, Cole JH, Cohen-Woods S, Costafreda SG, Simmons A, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 206: 379-84. PMID 25745134 DOI: 10.1192/Bjp.Bp.113.143529 |
0.332 |
|
| 2015 |
Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, ... ... Aitchison KJ, et al. Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. Psychological Medicine. 1-11. PMID 25698070 DOI: 10.1017/S0033291715000215 |
0.331 |
|
| 2014 |
Mullins N, Hodgson K, Tansey KE, Perroud N, Maier W, Mors O, Rietschel M, Hauser J, Henigsberg N, Souery D, Aitchison K, Farmer A, McGuffin P, Breen G, Uher R, et al. Investigation of blood mRNA biomarkers for suicidality in an independent sample. Translational Psychiatry. 4: e474. PMID 25350297 DOI: 10.1038/Tp.2014.112 |
0.328 |
|
| 2014 |
Vyas NS, Ahn K, Stahl DR, Caviston P, Simic M, Netherwood S, Puri BK, Lee Y, Aitchison KJ. Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder. Psychiatry Research. 220: 37-43. PMID 25146696 DOI: 10.1016/J.Psychres.2014.07.024 |
0.324 |
|
| 2014 |
Hung CF, Rivera M, Craddock N, Owen MJ, Gill M, Korszun A, Maier W, Mors O, Preisig M, Rice JP, Rietschel M, Jones L, Middleton L, Aitchison KJ, Davis OS, et al. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. The British Journal of Psychiatry : the Journal of Mental Science. 205: 24-8. PMID 24809401 DOI: 10.1192/Bjp.Bp.113.130419 |
0.346 |
|
| 2014 |
Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG. NPAS3 variants in schizophrenia: a neuroimaging study. Bmc Medical Genetics. 15: 37. PMID 24674381 DOI: 10.1186/1471-2350-15-37 |
0.351 |
|
| 2014 |
Koola MM, Tsapakis EM, Wright P, Smith S, Kerwin Rip RW, Nugent KL, Aitchison KJ. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? Journal of Psychopharmacology (Oxford, England). 28: 665-670. PMID 24595968 DOI: 10.1177/0269881114523861 |
0.315 |
|
| 2014 |
Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse (New York, N.Y.). 68: 209-20. PMID 24458505 DOI: 10.1002/Syn.21732 |
0.322 |
|
| 2014 |
Tansey KE, Rucker JJ, Kavanagh DH, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans DM, Hauser J, Henigsberg N, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. The Pharmacogenomics Journal. 14: 395-9. PMID 24445990 DOI: 10.1038/Tpj.2013.51 |
0.386 |
|
| 2014 |
Hodgson K, Uher R, Crawford AA, Lewis G, O'Donovan MC, Keers R, Dernovsek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison K, et al. Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. Journal of Psychopharmacology (Oxford, England). 28: 142-50. PMID 24414086 DOI: 10.1177/0269881113517957 |
0.413 |
|
| 2014 |
Hodgson K, Tansey K, Dernovsek MZ, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Smith R, Craig IW, Farmer AE, Aitchison KJ, Belsy S, et al. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. Journal of Psychopharmacology (Oxford, England). 28: 133-41. PMID 24257813 DOI: 10.1177/0269881113512041 |
0.364 |
|
| 2013 |
Power RA, Cohen-Woods S, Ng MY, Butler AW, Craddock N, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, Zobel A, Mors O, Placentino A, Rietschel M, ... Aitchison KJ, et al. Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 521-9. PMID 23857890 DOI: 10.1002/Ajmg.B.32180 |
0.327 |
|
| 2013 |
Costafreda SG, McCann P, Saker P, Cole JH, Cohen-Woods S, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. Journal of Affective Disorders. 150: 96-103. PMID 23643106 DOI: 10.1016/J.Jad.2013.02.028 |
0.375 |
|
| 2013 |
Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T, Farmer AE, Aitchison KJ, Craig IW, Danese A, Lewis C, McGuffin P, Uher R, Tansey KE, D'Souza UM. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1105-14. PMID 23142150 DOI: 10.1016/J.Euroneuro.2012.09.009 |
0.318 |
|
| 2013 |
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 377-85. PMID 22990943 DOI: 10.1038/Npp.2012.191 |
0.305 |
|
| 2013 |
Rucker JJ, Breen G, Pinto D, Pedroso I, Lewis CM, Cohen-Woods S, Uher R, Schosser A, Rivera M, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, et al. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry. 18: 183-9. PMID 22042228 DOI: 10.1038/Mp.2011.144 |
0.351 |
|
| 2013 |
Uher R, Tansey KE, Rietschel M, Henigsberg N, Maier W, Mors O, Hauser J, Placentino A, Souery D, Farmer A, Aitchison KJ, Craig I, McGuffin P, Lewis CM, Ising M, et al. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies American Journal of Psychiatry. 170: 207-217. DOI: 10.1176/Appi.Ajp.2012.12020237 |
0.373 |
|
| 2013 |
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. Erratum: Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’ Neuropsychopharmacology. 38: 376-376. DOI: 10.1038/Npp.2012.211 |
0.318 |
|
| 2013 |
Hodgson K, Tansey K, Uher R, Daivs O, Aitchison K, McGuffin P. P.4.002 Genetic differences in drug-metabolising enzymes: can they be used to predict antidepressant treatment response? European Neuropsychopharmacology. 23: S69-S70. DOI: 10.1016/S0924-977X(13)70077-4 |
0.313 |
|
| 2012 |
Tansey KE, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans D, Hall SK, Hauser J, Henigsberg N, Hu X, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. Plos Medicine. 9: e1001326. PMID 23091423 DOI: 10.1371/Journal.Pmed.1001326 |
0.39 |
|
| 2012 |
Power RA, Keers R, Ng MY, Butler AW, Uher R, Cohen-Woods S, Ising M, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Hauser J, ... ... Aitchison KJ, et al. Dissecting the genetic heterogeneity of depression through age at onset. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 859-68. PMID 22915352 DOI: 10.1002/Ajmg.B.32093 |
0.366 |
|
| 2012 |
Keers R, Pedroso I, Breen G, Aitchison KJ, Nolan PM, Cichon S, Nöthen MM, Rietschel M, Schalkwyk LC, Fernandes C. Reduced anxiety and depression-like behaviours in the circadian period mutant mouse afterhours. Plos One. 7: e38263. PMID 22719873 DOI: 10.1371/Journal.Pone.0038263 |
0.346 |
|
| 2012 |
Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P, Fu CH. White matter abnormalities and illness severity in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 201: 33-9. PMID 22576724 DOI: 10.1192/Bjp.Bp.111.100594 |
0.315 |
|
| 2012 |
Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. Journal of Psychopharmacology (Oxford, England). 26: 408-18. PMID 22303032 DOI: 10.1177/0269881111434624 |
0.524 |
|
| 2012 |
Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. Journal of Psychopharmacology (Oxford, England). 26: 419-28. PMID 21969106 DOI: 10.1177/0269881111415737 |
0.527 |
|
| 2012 |
Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychological Medicine. 42: 967-80. PMID 21929846 DOI: 10.1017/S0033291711001905 |
0.329 |
|
| 2012 |
Huezo-Diaz P, Perroud N, Spencer EP, Smith R, Sim S, Virding S, Uher R, Gunasinghe C, Gray J, Campbell D, Hauser J, Maier W, Marusic A, Rietschel M, Perez J, ... ... Aitchison KJ, et al. CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. Journal of Psychopharmacology (Oxford, England). 26: 398-407. PMID 21926427 DOI: 10.1177/0269881111414451 |
0.329 |
|
| 2012 |
Rivera M, Cohen-Woods S, Kapur K, Breen G, Ng MY, Butler AW, Craddock N, Gill M, Korszun A, Maier W, Mors O, Owen MJ, Preisig M, Bergmann S, Tozzi F, ... ... Aitchison KJ, et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry. 17: 604-11. PMID 21502950 DOI: 10.1038/Mp.2011.45 |
0.371 |
|
| 2012 |
Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, ... ... Aitchison KJ, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. The Pharmacogenomics Journal. 12: 68-77. PMID 20877300 DOI: 10.1038/Tpj.2010.70 |
0.372 |
|
| 2012 |
Cattaneo A, Gennarelli M, Rudolf U, Breen G, Farmer A, Aitchison KJ, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. P.2.c.028 Candidate genes expression profile associated with antidepressants response: baseline predictors and longitudinal targets European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70401-7 |
0.315 |
|
| 2012 |
Palaniyappan L, Balain V, Simmonite M, Carrol L, McGuffin P, Aitchison K, Liddle PF. Poster #108 THE INFLUENCE OF DISC1 SER704CYS POLYMORPHISM ON THE CORTICAL THICKNESS OF SALIENCE NETWORK (INSULA AND ANTERIOR CINGULATE) IN PSYCHOSIS Schizophrenia Research. 136: S319. DOI: 10.1016/S0920-9964(12)70941-6 |
0.376 |
|
| 2011 |
Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, Henigsberg N, Mendlewicz J, Aitchison KJ, Farmer A, McGuffin P. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. The Journal of Clinical Psychiatry. 72: 1478-84. PMID 22127194 DOI: 10.4088/Jcp.10M06419 |
0.34 |
|
| 2011 |
Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, ... ... Aitchison KJ, et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. Plos One. 6: e20690. PMID 21750702 DOI: 10.1371/Journal.Pone.0020690 |
0.361 |
|
| 2011 |
Uher R, Dernovsek MZ, Mors O, Hauser J, Souery D, Zobel A, Maier W, Henigsberg N, Kalember P, Rietschel M, Placentino A, Mendlewicz J, Aitchison KJ, McGuffin P, Farmer A. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders. 132: 112-20. PMID 21411156 DOI: 10.1016/J.Jad.2011.02.014 |
0.305 |
|
| 2011 |
Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, ... Aitchison KJ, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 528-38. PMID 21388237 DOI: 10.3109/15622975.2011.559270 |
0.344 |
|
| 2011 |
Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics. 11: 101-25. PMID 21158559 DOI: 10.1586/Ern.10.186 |
0.346 |
|
| 2011 |
Malki K, Uher R, Paya-Cano J, Binder E, Rietschel M, Zobel A, Mors O, Hauser J, Henigsberg N, Jerman B, Souery D, Placentino A, Ng MY, Cohen-Woods S, Sluyter F, ... ... Aitchison KJ, et al. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological Psychiatry. 69: 360-5. PMID 20970119 DOI: 10.1016/J.Biopsych.2010.08.011 |
0.359 |
|
| 2011 |
Keers R, Bonvicini C, Scassellati C, Uher R, Placentino A, Giovannini C, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Hauser J, Souery D, Mendlewicz J, Schmäl C, ... ... Aitchison KJ, et al. Variation in GNB3 predicts response and adverse reactions to antidepressants. Journal of Psychopharmacology (Oxford, England). 25: 867-74. PMID 20826553 DOI: 10.1177/0269881110376683 |
0.399 |
|
| 2011 |
Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Zobel A, Hauser J, Souery D, Placentino A, Larsen ER, ... ... Aitchison KJ, et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 11: 138-45. PMID 20212518 DOI: 10.1038/Tpj.2010.14 |
0.37 |
|
| 2011 |
Rucker J, Aitchison K, Cohen-Woods S, Lewis C, Uher R, Craddock M, Owen M, Muglia P, Breen G, McGuffin P. P.1.034 Copy number variants in CYP450 psychotropic drug metabolising enzymes in a large study of recurrent depressive disorder European Neuropsychopharmacology. 21: S28. DOI: 10.1016/S0924-977X(11)70033-5 |
0.338 |
|
| 2010 |
Drago A, Serretti A, Smith R, Huezo-Diaz P, Malitas P, Albani D, Ronchi DD, Pae CU, Aitchison KJ. No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample. International Journal of Psychiatry in Clinical Practice. 14: 154-7. PMID 24922477 DOI: 10.3109/13651501003706717 |
0.349 |
|
| 2010 |
Keers R, Aitchison KJ. Gender differences in antidepressant drug response. International Review of Psychiatry (Abingdon, England). 22: 485-500. PMID 21047161 DOI: 10.3109/09540261.2010.496448 |
0.305 |
|
| 2010 |
Keers R, Uher R, Gupta B, Rietschel M, Schulze TG, Hauser J, Skibinska M, Henigsberg N, Kalember P, Maier W, Zobel A, Mors O, Kristensen AS, Kozel D, Giovannini C, ... ... Aitchison KJ, et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. Journal of Affective Disorders. 127: 337-42. PMID 20609482 DOI: 10.1016/J.Jad.2010.06.011 |
0.322 |
|
| 2010 |
Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, Rivera M, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, ... Aitchison KJ, et al. Genome-wide association study of major recurrent depression in the U.K. population. The American Journal of Psychiatry. 167: 949-57. PMID 20516156 DOI: 10.1176/Appi.Ajp.2010.09091380 |
0.37 |
|
| 2010 |
McGuffin P, Perroud N, Uher R, Butler A, Aitchison KJ, Craig I, Lewis C, Farmer A. The genetics of affective disorder and suicide. European Psychiatry : the Journal of the Association of European Psychiatrists. 25: 275-7. PMID 20462744 DOI: 10.1016/J.Eurpsy.2009.12.012 |
0.311 |
|
| 2010 |
Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, ... ... Aitchison KJ, et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. The American Journal of Psychiatry. 167: 555-64. PMID 20360315 DOI: 10.1176/Appi.Ajp.2009.09070932 |
0.397 |
|
| 2010 |
Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry. 67: 550-7. PMID 20034614 DOI: 10.1016/J.Biopsych.2009.11.005 |
0.35 |
|
| 2010 |
Uher R, Muthén B, Souery D, Mors O, Jaracz J, Placentino A, Petrovic A, Zobel A, Henigsberg N, Rietschel M, Aitchison KJ, Farmer A, McGuffin P. Trajectories of change in depression severity during treatment with antidepressants. Psychological Medicine. 40: 1367-77. PMID 19863842 DOI: 10.1017/S0033291709991528 |
0.334 |
|
| 2010 |
Perroud N, Uher R, Hauser J, Rietschel M, Henigsberg N, Placentino A, Kozel D, Maier W, Mors O, Souery D, Dmitrzak-Weglarz M, Jorgensen L, Kovacic Z, Giovannini C, Mendlewicz J, ... ... Aitchison KJ, et al. History of suicide attempts among patients with depression in the GENDEP project. Journal of Affective Disorders. 123: 131-7. PMID 19772940 DOI: 10.1016/J.Jad.2009.09.001 |
0.337 |
|
| 2010 |
Aitchison KJ. Clinical lessons from GENDEP for the treatment of depression Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S6 |
0.324 |
|
| 2009 |
Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Souery D, Placentino A, Szczepankiewicz A, Jorgensen L, Strohmaier J, Zobel A, Giovannini C, ... ... Aitchison KJ, et al. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. Bmc Medicine. 7: 60. PMID 19832967 DOI: 10.1186/1741-7015-7-60 |
0.302 |
|
| 2009 |
Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, Maier W, Mors O, Placentino A, Henigsberg N, Rietschel M, Hauser J, Souery D, Kapelski P, Bonvicini C, et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2517-28. PMID 19641488 DOI: 10.1038/Npp.2009.81 |
0.385 |
|
| 2009 |
Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, ... ... Aitchison KJ, et al. Moderation of antidepressant response by the serotonin transporter gene. The British Journal of Psychiatry : the Journal of Mental Science. 195: 30-8. PMID 19567893 DOI: 10.1192/Bjp.Bp.108.062521 |
0.385 |
|
| 2009 |
Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, ... ... Aitchison KJ, et al. Genetic predictors of response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 9: 225-33. PMID 19365399 DOI: 10.1038/Tpj.2009.12 |
0.411 |
|
| 2009 |
Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, Henigsberg N, Souery D, Placentino A, Rietschel M, Zobel A, Dmitrzak-Weglarz M, Petrovic A, Jorgensen L, Kalember P, ... ... Aitchison KJ, et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. The British Journal of Psychiatry : the Journal of Mental Science. 194: 252-9. PMID 19252156 DOI: 10.1192/Bjp.Bp.108.057554 |
0.315 |
|
| 2009 |
Keers R, Farmer AE, Aitchison KJ. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychological Medicine. 39: 1231-5. PMID 19215628 DOI: 10.1017/S0033291708005084 |
0.326 |
|
| 2009 |
Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry. 14: 1095-104. PMID 18458677 DOI: 10.1038/Mp.2008.48 |
0.341 |
|
| 2008 |
Forti MD, Morgan C, Mondelli V, Gittens L, Russo M, Handley R, Marquez T, Masson S, Prescott C, Hepgul N, Wiffen B, Pariante C, Aitchison K, Dazzan P, Powell J, et al. Patients With First Episode Psychosis Take More And Stronger Cannabis Than Controls: The Genetics And Psychosis (Gap) Study Schizophrenia Research. 102: 247. DOI: 10.1016/S0920-9964(08)70744-8 |
0.3 |
|
| 2008 |
Tsapakis E, Sugden K, Kinirons M, Scully P, Quinn J, Wright P, Smith S, Murray R, Daly A, Gill M, Waddington J, Kerwin R, Aitchison K. Association Between Alpha2-Receptor Variants And Movement Disorders Schizophrenia Research. 102: 192. DOI: 10.1016/S0920-9964(08)70582-6 |
0.468 |
|
| 2007 |
Su KP, Peng CY, Liao KF, Lai HC, Huang CL, Cheng JC, Aitchison K, Pariante C. P.2.b.005 Polymorphisms in cytosolic phospholipase A2 and cyclooxygenase 2 genes and risk of interferon-induced depression European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70482-0 |
0.335 |
|
| 2006 |
Carboni L, Piubelli C, Vighini M, Khoury AE, Gruber S, Anderssen W, Mathé AA, Aitchison KJ, Mallei A, Giambelli R, Popoli M, Domenici E. P.2.d.007 Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatment European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70378-9 |
0.306 |
|
| 2005 |
Huezo-Diaz P, Tandon K, Aitchison KJ. The genetics of depression and related traits. Current Psychiatry Reports. 7: 117-24. PMID 15802088 DOI: 10.1007/S11920-005-0008-5 |
0.341 |
|
| 2005 |
Aitchison KJ, Basu A, McGuffin P, Craig I. Psychiatry and the 'new genetics': hunting for genes for behaviour and drug response. The British Journal of Psychiatry : the Journal of Mental Science. 186: 91-2. PMID 15684228 DOI: 10.1192/Bjp.186.2.91 |
0.317 |
|
| 2005 |
Basu A, Aitchison KJ. Pharmacogenetics: antidepressant drug response Psychiatry. 4: 30-34. DOI: 10.1383/Psyt.2005.4.12.30 |
0.382 |
|
| 2005 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.32 Association between the serotonin transporter linked polymorphic region gene and response to tricyclic antidepressants European Neuropsychopharmacology. 15: S26-S27. DOI: 10.1016/S0924-977X(05)80137-3 |
0.541 |
|
| 2004 |
Basu A, Tsapakis E, Aitchison K. Pharmacogenetics and psychiatry. Current Psychiatry Reports. 6: 134-142. PMID 15038916 DOI: 10.1007/S11920-004-0053-5 |
0.31 |
|
| 2004 |
Tsapakis EM, Basu A, Aitchison KJ. Clinical relevance of discoveries in psychopharmacogenetics Advances in Psychiatric Treatment. 10: 455-465. DOI: 10.1192/Apt.10.6.455 |
0.309 |
|
| 2003 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.178 Association between the serotonin transporter linked polymorphic region gene (5-HTTLPR) and response to tricyclic antidepressants (TCAs) European Neuropsychopharmacology. 13: S250. DOI: 10.1016/S0924-977X(03)91888-8 |
0.542 |
|
| 2002 |
Tandon K, Schalkwyk L, Patel M, Kinirons M, Kerwin R, McGuffin P, Aitchison K. An amino acid substitution (Ile109Val) in CYP2D6 European Neuropsychopharmacology. 12: 405. DOI: 10.1016/S0924-977X(02)80692-7 |
0.416 |
|
| 2002 |
Aitchison K, Tandon K, Ashworth A, Kerwin R, McGuffin P. Pharmacogenetic studies of tricyclic antidepressant response and an association study of a noradrenaline transporter variant in depression European Neuropsychopharmacology. 12: 92-93. DOI: 10.1016/S0924-977X(02)80022-0 |
0.526 |
|
| 2001 |
Aitchison KJ, Zhao JH, Munro J, Collier DA, Makoff AJ, Kerwin RW. Investigation of an association between a CYP1A2 5′ flanking SNP (T-3591G) and response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 582. |
0.432 |
|
| 2000 |
Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. Journal of Psychopharmacology (Oxford, England). 14: 353-9. PMID 11198052 DOI: 10.1177/026988110001400403 |
0.457 |
|
| 2000 |
Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics. 10: 695-704. PMID 11186132 DOI: 10.1097/00008571-200011000-00004 |
0.485 |
|
| 2000 |
Aitchison KJ, Jordan BD, Sharma T. The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis. Drug Metabolism and Drug Interactions. 16: 15-38. PMID 10820581 DOI: 10.1515/Dmdi.2000.16.1.15 |
0.302 |
|
| 2000 |
Makoff AJ, Graham JM, Arranz MJ, Forsyth J, Li T, Aitchison KJ, Shaikh S, Grünewald RA. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 10: 43-8. PMID 10739171 DOI: 10.1097/00008571-200002000-00006 |
0.556 |
|
| 2000 |
Aitchison K, Jann M, Wolff K, Sakai T, Makoff A, Collier D, Gonzalez F, Kerwin R. Clozapine pharmacokinetics studied with CYP1A2 knockout mice Schizophrenia Research. 41: 235. DOI: 10.1016/S0920-9964(00)90889-2 |
0.44 |
|
| 1999 |
Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology. 48: 388-94. PMID 10510151 DOI: 10.1046/J.1365-2125.1999.00006.X |
0.535 |
|
| 1999 |
Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Research. 86: 193-201. PMID 10482338 DOI: 10.1016/S0165-1781(99)00034-7 |
0.574 |
|
| 1998 |
Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 32: 87-92. PMID 9713903 DOI: 10.1016/S0920-9964(98)00024-3 |
0.655 |
|
| 1998 |
Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease. Biological Psychiatry. 43: 159-64. PMID 9494696 DOI: 10.1016/S0006-3223(97)00326-0 |
0.33 |
|
| 1997 |
Kerwin RW, Aitchison KJ. Cost-effectiveness of clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 171: 584. PMID 9519106 |
0.368 |
|
| 1997 |
Aitchison KJ, Kerwin RW. Cost-effectiveness of clozapine. A UK clinic-based study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 125-30. PMID 9337946 DOI: 10.1192/Bjp.171.2.125 |
0.479 |
|
| 1997 |
Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological Psychiatry. 42: 282-5. PMID 9270905 DOI: 10.1016/S0006-3223(96)00366-6 |
0.565 |
|
| 1997 |
Sodhi MS, Kirov G, Aitchison KJ, Arranz MJ, Collier DA, Kerwin RW. Allelic variation of the 5-HT2C receptor in psychosis Schizophrenia Research. 24: 90-91. DOI: 10.1016/S0920-9964(97)82246-3 |
0.621 |
|
| 1997 |
Aitchison KJ, Munro J, Wright P, Chapman S, Collier DA, Kerwin RW. Pharmacogenetic factors in treatment-resistant schizophrenia: The role of CYP2D6 variants Schizophrenia Research. 24: 89. DOI: 10.1016/S0920-9964(97)82242-6 |
0.493 |
|
| 1996 |
Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A, Kunugi H, Vallada H, Leigh PN, Chaudhuri KR, Collier DA. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochemical and Biophysical Research Communications. 228: 780-4. PMID 8941353 DOI: 10.1006/Bbrc.1996.1731 |
0.549 |
|
| 1996 |
Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 7: 1675-9. PMID 8904780 DOI: 10.1097/00001756-199607080-00030 |
0.687 |
|
| 1996 |
Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 97: 714-9. PMID 8641685 DOI: 10.1007/Bf02346178 |
0.57 |
|
| 1996 |
Kerwin R, Aitchison K. Cost-effectiveness of treatments for schizophrenia European Neuropsychopharmacology. 6: S4-54. DOI: 10.1016/0924-977X(96)82924-5 |
0.422 |
|
| 1996 |
Aitchison K, Kerwin R. The pharmaco-economics of schizophrenia: New horizons European Psychiatry. 11: 225s. DOI: 10.1016/0924-9338(96)88668-8 |
0.403 |
|
| 1996 |
Sodhi M, Kirov G, Arranz M, Ball D, Aitchison K, Kerwin R, Collier D. Association between psychoses and allelic variation in the 5-HT2C receptor gene Schizophrenia Research. 18: 164. DOI: 10.1016/0920-9964(96)85524-1 |
0.642 |
|
| 1996 |
Shaikh S, Collier D, Sham P, Aitchison K, Ball D, Gill M, Kerwin R. Allelic association between a ser-9-gly polymorphism in the D3 receptor gene and schizophrenia Schizophrenia Research. 18: 163. DOI: 10.1016/0920-9964(96)85520-4 |
0.547 |
|
| 1996 |
Aitchison K, Patel M, Taylor M, Murray R, Arranz M, Collier D, Kerwin R. Neuroleptic sensitivity and enzyme deficiency in two schizophrenic brothers: A case report Schizophrenia Research. 18: 152. DOI: 10.1016/0920-9964(96)85496-X |
0.441 |
|
| 1996 |
Sodhi MS, Arranz MJ, Kirov G, Ball DM, Aitchison KJ, Abusaad I, Kerwin RW, Collier DA. Association between psychoses and allelic variation in 5-HT2A and 5-HT2C receptor genes British Journal of Clinical Pharmacology. 41: 457P. |
0.627 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, Crocq MA, Gill M, Kerwin R, Collier DA. Cytochrome P4502D6 genotype does not determine response to clozapine. British Journal of Clinical Pharmacology. 39: 417-20. PMID 7640149 DOI: 10.1111/J.1365-2125.1995.Tb04471.X |
0.65 |
|
| 1995 |
Aitchison K, Kerwin R. The costs and benefits of clozapine therapy in the UK Schizophrenia Research. 15: 141. DOI: 10.1016/0920-9964(95)95436-D |
0.358 |
|
| 1995 |
Arranz M, Aitchison K, Kerwin R, Collier D. Analyses of clozapine response and the 5-HT2 gene Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95114-O |
0.473 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sharma T, Aitchison K, Crog MA, Gill M, Kerwin R, Collier DA. Cytochrome P450IID6 genotype does not determine response to clozapine Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95112-M |
0.51 |
|
| Show low-probability matches. |